Tyrosine Kinase InhibitorsaAdvances in Research and Application: 2012 Edition is a ScholarlyBriefac that delivers timely, authoritative, comprehensive, and specialized information about Tyrosine Kinase Inhibitors in a concise format. The editors have built Tyrosine Kinase InhibitorsaAdvances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.ac You can expect the information about Tyrosine Kinase Inhibitors in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Tyrosine Kinase InhibitorsaAdvances in Research and Application: 2012 Edition has been produced by the worldas leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditionsac and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.Chemotherapy for Stage IV Non-Small-Cell Lung Cancer (NSCLC) regarding switch maintenance chemotherapy, a ... Data detailed in a#39;The SATURN trial: the value of maintenance erlotinib in patients with non-small-cell lung cancera#39; have beenanbsp;...
|Title||:||Tyrosine Kinase Inhibitors—Advances in Research and Application: 2012 Edition|
|Publisher||:||ScholarlyEditions - 2012-12-26|